<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Genetic disorders causing congenital diarrheas and enteropathies (CODEs)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Genetic disorders causing congenital diarrheas and enteropathies (CODEs)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Genetic disorders causing congenital diarrheas and enteropathies (CODEs)</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Disorder</td> <td class="subtitle1" colspan="2">Gene</td> <td class="subtitle1" rowspan="2">Protein function</td> <td class="subtitle1" colspan="3">Clinical characteristics</td> </tr> <tr> <td class="subtitle2">Name</td> <td class="subtitle2">Inheritance</td> <td class="subtitle2">Diarrhea type</td> <td class="subtitle2">Biopsy</td> <td class="subtitle2">Other characteristics</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Epithelial electrolyte transport</td> </tr> <tr> <td class="indent1"> <p>Congenital chloride diarrhea</p> (<a href="https://www.omim.org/entry/214700" target="_blank">MIM #214700</a>)</td> <td><em><a href="https://www.omim.org/entry/126650" target="_blank">SLC26A3</a></em></td> <td>AR</td> <td><span class="nowrap_whitespace">Cl<sup>–</sup>/HCO<sub>3</sub><sup>–</sup></span> exchanger</td> <td>Severe watery, ETRD*</td> <td>Normal</td> <td>Polyhydramnios; high fecal <span class="nowrap_whitespace">Cl<sup>–</sup></span> (&gt;90 mM); hypochloremic hypokalemic metabolic alkalosis.</td> </tr> <tr> <td class="indent1"> <p>Congenital sodium diarrhea</p> (<a href="https://www.omim.org/entry/616868" target="_blank">MIM #616868</a>)</td> <td><em><a href="https://www.omim.org/entry/182307" target="_blank">SLC9A3</a></em></td> <td>AR</td> <td><span class="nowrap_whitespace">Na<sup>+</sup>/H<sup>+</sup></span> exchanger (NHE3)</td> <td>Severe, watery, ETRD</td> <td>Normal</td> <td>Polyhydramnios; diarrhea features similar to above, but with high fecal <span class="nowrap_whitespace">Na<sup>+</sup></span> content (typically &gt;140 mM) and metabolic acidosis.</td> </tr> <tr> <td class="indent1"> <p>Familial <em>GUCY2C</em> diarrhea</p> (<a href="https://www.omim.org/entry/614616" target="_blank">MIM #614616</a>)</td> <td><em><a href="https://www.omim.org/entry/601330" target="_blank">GUCY2C</a></em> (gain of function)</td> <td>AD</td> <td>Guanylate cyclase</td> <td>Mild, watery, ETRD</td> <td>Normal</td> <td>Early-onset mild diarrhea, with increased intraluminal chloride, metabolic acidosis, and susceptibility to IBD.</td> </tr> <tr> <td class="indent1"> <p>Pseudohyperaldosteronism type 1</p> (<a href="https://www.omim.org/entry/264350" target="_blank">MIM #264350</a>)</td> <td> <p><em><a href="https://www.omim.org/entry/600228" target="_blank">SCNN1A</a></em></p> <p><em><a href="https://www.omim.org/entry/600760" target="_blank">SCNN1B</a></em></p> <em><a href="https://www.omim.org/entry/600761" target="_blank">SCNN1G</a></em></td> <td>AR</td> <td>Epithelial Na<sup>+</sup> channel</td> <td>Severe, watery, ETRD</td> <td>Normal</td> <td>Hypotension, <span class="nowrap_whitespace">Na<sup>+</sup>-wasting</span> in urine and stools. Elevated serum aldosterone levels. Channels regulated by the renin-angiotensin-aldosterone system.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Epithelial nutrient transport</td> </tr> <tr> <td class="indent1"> <p>Glucose-galactose malabsorption</p> (<a href="https://www.omim.org/entry/606824" target="_blank">MIM #606824</a>)</td> <td><em><a href="https://www.omim.org/entry/182380" target="_blank">SLC5A1</a></em></td> <td>AR</td> <td><span class="nowrap_whitespace">Na<sup>+</sup>-glucose</span> cotransporter</td> <td>Severe, watery, diet-induced</td> <td>Normal</td> <td>Diarrhea resolves with fasting or with a glucose- and galactose-free diet; severe dehydration; metabolic acidosis.</td> </tr> <tr> <td class="indent1"> <p>Lysinuric protein intolerance</p> (<a href="https://www.omim.org/entry/222700" target="_blank">MIM #222700</a>)</td> <td><em><a href="https://www.omim.org/entry/603593" target="_blank">SLC7A7</a></em></td> <td>AR</td> <td>Cationic amino acid transporter (intestine and kidney)</td> <td>Watery diarrhea</td> <td>Normal</td> <td>Episodes of diarrhea, vomiting, and acute encephalopathy, with hyperammonemia induced by protein consumption.</td> </tr> <tr> <td class="indent1" rowspan="2"> <p>Primary bile acid diarrhea</p> (<a href="https://www.omim.org/entry/613291" target="_blank">MIM #613291</a>)</td> <td><em><a href="https://www.omim.org/entry/601295" target="_blank">SLC10A2</a></em></td> <td>AR</td> <td>Ileal bile salt transporters</td> <td rowspan="2">Watery/fatty; both ETRD and diet-induced</td> <td rowspan="2">Normal</td> <td rowspan="2">Excessive colonic <span class="nowrap_whitespace">Cl<sup>–</sup></span> secretion; fat malabsorption due to lack of bile acid reuptake and insufficient intraluminal bile acids. Unlike other forms of ETRD, feedings worsen the diarrhea. Fat-soluble vitamin deficiency; cholestatic liver disease.</td> </tr> <tr> <td><em><a href="https://www.omim.org/entry/612085" target="_blank">SLC51B</a></em></td> <td>AR</td> <td>Basolateral bile acid transporter</td> </tr> <tr> <td class="indent1"> <p>Acrodermatitis enteropathica</p> (<a href="https://www.omim.org/entry/201100" target="_blank">MIM #201100</a>)</td> <td><em><a href="https://www.omim.org/entry/607059" target="_blank">SLC39A4</a></em></td> <td>AR</td> <td>Zinc transporter</td> <td>Watery</td> <td>Normal</td> <td>Erythematous vesiculobullous acrodermatitis (typically on cheeks and buttocks); diarrhea; alopecia; ophthalmic disorders; low serum zinc.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Epithelial enzymes and metabolism</td> </tr> <tr> <td class="indent1"> <p>Congenital lactase deficiency</p> (<a href="https://www.omim.org/entry/223000" target="_blank">MIM #223000</a>)</td> <td><em><a href="https://www.omim.org/entry/603202" target="_blank">LCT</a></em></td> <td>AR</td> <td>Disaccharidase</td> <td>Watery, diet-induced</td> <td>Normal</td> <td>Diarrhea resolves with fasting or a lactose-free diet. Must be distinguished from secondary lactose intolerance, which is induced by mucosal injury (eg, after an enteric infection) and is transient.</td> </tr> <tr> <td class="indent1"> <p>Sucrase-isomaltase deficiency</p> (<a href="https://www.omim.org/entry/222900" target="_blank">MIM #222900</a>)</td> <td><em><a href="https://www.omim.org/entry/609845" target="_blank">SI</a></em></td> <td>AR</td> <td>Disaccharidase</td> <td>Watery, diet-induced</td> <td>Normal</td> <td>Diarrhea resolves with fasting or a carbohydrate-free diet (no sucrose, maltose, or starch). Young infants are asymptomatic because sucrose is absent in breast milk and is not common in formulas.</td> </tr> <tr> <td class="indent1"> <p>Trehalase deficiency</p> (<a href="https://www.omim.org/entry/612119" target="_blank">MIM #612119</a>)</td> <td><em><a href="https://www.omim.org/entry/275360" target="_blank">TREH</a></em></td> <td>AR</td> <td>Disaccharidase</td> <td>Watery</td> <td>Normal</td> <td>Diarrhea associated with a dose-dependent consumption of a trehalose-containing diet (eg, mushrooms or foods produced with bakers' yeast). Young infants are asymptomatic because trehalose is not typically in infant formula or breast milk.</td> </tr> <tr> <td class="indent1"> <p>Enterokinase deficiency</p> (<a href="https://www.omim.org/entry/226200" target="_blank">MIM #226200</a>)</td> <td><em><a href="https://www.omim.org/entry/606635" target="_blank">PRSS7</a></em></td> <td>AR</td> <td>Pro-enterokinase</td> <td>Watery, diet-induced</td> <td>Normal</td> <td>Diarrhea improves on an amino acid-based diet.</td> </tr> <tr> <td class="indent1"> <p>DGAT1 deficiency</p> (<a href="https://www.omim.org/entry/615863" target="_blank">MIM #615863</a>)</td> <td><em><a href="https://www.omim.org/entry/604900" target="_blank">DGAT1</a></em></td> <td>AR</td> <td>Triglyceride synthesis</td> <td>Watery, diet-induced</td> <td>Abnormal villi; positive PAS stain.</td> <td>Diarrhea induced by enteral lipids, with features of ETRD*; severe protein-losing enteropathy with hypoalbuminemia; emesis; growth failure.</td> </tr> <tr> <td class="indent1"> <p>Hennekam lymphangiectasia-lymphedema syndrome-1</p> (<a href="https://www.omim.org/entry/235510" target="_blank">MIM #235510</a>)</td> <td><em><a href="https://www.omim.org/entry/612753" target="_blank">CCBE1</a></em></td> <td>AR</td> <td>Budding of venous endothelium</td> <td>Watery</td> <td>Intestinal lymphangiectasia</td> <td>Diarrhea; protein-losing enteropathy; facial dysmorphism; cognitive impairment.</td> </tr> <tr> <td class="indent1"> <p>PLVAP deficiency</p> (<a href="https://www.omim.org/entry/226300" target="_blank">MIM #226300</a>)</td> <td><em><a href="https://www.omim.org/entry/607647" target="_blank">PLVAP</a></em></td> <td>AR</td> <td>Endothelial fenestrae</td> <td>Watery, diet-induced</td> <td>Normal</td> <td>Severe protein-losing enteropathy with hypoalbuminemia; hypertriglyceridemia. Very rare.</td> </tr> <tr> <td class="indent1"> <p>Abetalipoproteinemia</p> (<a href="https://www.omim.org/entry/200100" target="_blank">MIM #200100</a>)</td> <td><em><a href="https://www.omim.org/entry/157147" target="_blank">MTP</a></em></td> <td>AR</td> <td>Microsomal triglyceride transfer protein</td> <td>Fatty, diet-induced</td> <td>Fat-laden enterocytes</td> <td>Low LDL with normal fecal elastase.</td> </tr> <tr> <td class="indent1" rowspan="2"> <p>Hypobetalipoproteinemia</p> <p>(<a href="https://www.omim.org/entry/615558" target="_blank">MIM #615558</a>)</p> (<a href="https://www.omim.org/entry/605019" target="_blank">MIM #605019</a>)</td> <td><em><a href="https://www.omim.org/entry/107730" target="_blank">APOB</a></em></td> <td>AR</td> <td>Lipid absorption</td> <td rowspan="2">Fatty, diet-induced</td> <td rowspan="2">Fat-laden enterocytes</td> <td rowspan="2">Low LDL with normal fecal elastase.</td> </tr> <tr> <td><em><a href="https://www.omim.org/entry/604774" target="_blank">ANGPTL3</a></em></td> <td>AR</td> <td>Inhibits lipoprotein lipase activity</td> </tr> <tr> <td class="indent1"> <p>Chylomicron retention disease</p> (<a href="https://www.omim.org/entry/246700" target="_blank">MIM #246700</a>)</td> <td><em><a href="https://www.omim.org/entry/607690" target="_blank">SAR1B</a></em></td> <td>AR</td> <td>Intracellular chylomicron trafficking</td> <td>Fatty, diet-induced</td> <td>Fat-laden enterocytes</td> <td>Low LDL with normal fecal elastase.</td> </tr> <tr> <td class="indent1"> <p>Dyskeratosis congenita</p> (<a href="https://www.omim.org/entry/613989" target="_blank">MIM #613989</a>)</td> <td><em><a href="https://www.omim.org/entry/187270" target="_blank">TERT</a></em></td> <td>AR/AD</td> <td>Maintenance of telomeres</td> <td>Watery and/or bloody</td> <td>Crypt apoptosis, increased intraepithelial lymphocytes, villus atrophy, and expanded lamina propria</td> <td>Variable age of presentation, which may include enteropathy. Multiple syndromes and genes involved.</td> </tr> <tr> <td class="indent1"> <p>Kabuki syndrome</p> (<a href="https://www.omim.org/entry/147920" target="_blank">MIM #147920</a>)</td> <td><em><a href="https://www.omim.org/entry/602113" target="_blank">KMT2D</a></em></td> <td>AD</td> <td>Histone methyltransferase</td> <td>Watery, but may be variable</td> <td>Normal, but may be inflammatory</td> <td>Syndromic disorder that may be associated with neonatal hypoglycemia, immunologic defects, and/or autoimmune diseases, including vitiligo.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Epithelial trafficking and polarity</td> </tr> <tr> <td class="indent1" rowspan="2"> <p>Microvillus inclusion disease</p> (<a href="https://www.omim.org/entry/251850" target="_blank">MIM #251850</a>)</td> <td><em><a href="https://www.omim.org/entry/606540" target="_blank">MYO5B</a></em></td> <td>AR</td> <td>Cellular trafficking, polarity, and signaling</td> <td rowspan="2">Severe watery ETRD</td> <td rowspan="2">Villus atrophy; microvillus inclusions on electron microscopy; positive CD10/villin stain</td> <td rowspan="2">Diarrhea improves but does not resolve with fasting. May include cholestatic liver disease.</td> </tr> <tr> <td><em><a href="https://www.omim.org/entry/600876" target="_blank">STX3</a></em></td> <td>AR</td> <td> </td> </tr> <tr> <td class="indent1"> <p>Tufting enteropathy</p> (<a href="https://www.omim.org/entry/613217" target="_blank">MIM #613217</a>)</td> <td><em><a href="https://www.omim.org/entry/185535" target="_blank">EPCAM</a></em></td> <td>AR</td> <td>Cell-cell adhesion and signaling</td> <td>Severe watery ETRD</td> <td>Villus atrophy and focal epithelial tufts in small and large bowel; positive MOC31 stain</td> <td>Diarrhea persists with fasting.</td> </tr> <tr> <td class="indent1"> <p>Syndromic <span class="nowrap_whitespace">Na<sup>+</sup></span> diarrhea</p> (<a href="https://www.omim.org/entry/270420" target="_blank">MIM #270420</a>)</td> <td><em><a href="https://www.omim.org/entry/605124" target="_blank">SPINT2</a></em></td> <td>AR</td> <td>Serine protease inhibitor</td> <td>Severe watery ETRD</td> <td>Tufting enteropathy-like features</td> <td>Choanal atresia; rarely, intestinal atresia.</td> </tr> <tr> <td class="indent1"> <p>Trichohepatoenteric syndrome 1 (THES1)</p> (<a href="https://www.omim.org/entry/222470" target="_blank">MIM #222470</a>)</td> <td><em><a href="https://www.omim.org/entry/614589" target="_blank">TTC37</a></em></td> <td>AR</td> <td>Cell polarity and signaling</td> <td rowspan="2">Watery/bloody</td> <td rowspan="2">Villus atrophy, mononuclear infiltrates</td> <td rowspan="2">Liver disease; immune defect; facial dysmorphism; abnormal hair.</td> </tr> <tr> <td class="indent1"> <p>Trichohepatoenteric syndrome 2 (THES2)</p> (<a href="https://www.omim.org/entry/614602" target="_blank">MIM #614602</a>)</td> <td><em><a href="https://www.omim.org/entry/600478" target="_blank">SKIV2L</a></em></td> <td>AR</td> <td>Helicase</td> </tr> <tr> <td class="indent1"> <p>Familial hemophagocytic lymphohistiocytosis 5</p> (<a href="https://www.omim.org/entry/613101" target="_blank">MIM #613101</a>)</td> <td><em><a href="https://www.omim.org/entry/601717" target="_blank">STXBP2</a></em></td> <td>AR</td> <td>Syntaxin-binding protein</td> <td>Mild, diet-induced</td> <td>Short apical microvilli</td> <td>Hemophagocytic lymphohistiocytosis (excessive immune activation, hepatitis, cytopenias); mild chronic diarrhea. Diarrhea may not resolve after bone marrow transplant.</td> </tr> <tr> <td class="indent1"> <p>TTC7A deficiency</p> (<a href="https://www.omim.org/entry/243150" target="_blank">MIM #243150</a>)</td> <td><em><a href="https://www.omim.org/entry/609332" target="_blank">TTC7A</a></em></td> <td>AR</td> <td>Protein transport and trafficking</td> <td>ETRD</td> <td>Enterocolitis, villus atrophy; chronic inflammation</td> <td>Intestinal atresias; underlying SCID.</td> </tr> <tr> <td class="indent1">UNC45A deficiency</td> <td><em><a href="https://www.omim.org/entry/611219" target="_blank">UNC45A</a></em></td> <td>AR</td> <td>Cellular trafficking, polarity, and signaling</td> <td>Severe watery ETRD</td> <td>Villus atrophy; microvillus inclusions on electron microscopy; positive CD10/villin stain</td> <td>Cholestasis; congenital diarrhea; impaired hearing; bone fragility.</td> </tr> <tr> <td class="indent1"> <p>MEDNIK syndrome</p> (<a href="https://www.omim.org/entry/609313" target="_blank">MIM #609313</a>)</td> <td><em><a href="https://www.omim.org/entry/603531" target="_blank">AP1S1</a></em></td> <td>AR</td> <td>Required for sorting of late-Golgi/trans-Golgi network</td> <td>Watery</td> <td>Enteropathy</td> <td>Intellectual disability; enteropathy; deafness; peripheral neuropathy; ichthyosis; keratoderma.</td> </tr> <tr> <td class="indent1"> <p>MIRAGE syndrome</p> (<a href="https://www.omim.org/entry/617053" target="_blank">MIM #617053</a>)</td> <td><em><a href="https://www.omim.org/entry/610456" target="_blank">SAMD9</a></em></td> <td>AR</td> <td>Downstream target of TNF-alpha</td> <td>Watery</td> <td>Enteropathy</td> <td>Enteropathy; myelodysplasia; infection; restriction of growth; adrenal hypoplasia; genital phenotypes.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Enteroendocrine cell dysfunction</td> </tr> <tr> <td class="indent1"> <p>Enteric anendocrinosis</p> (<a href="https://www.omim.org/entry/610370" target="_blank">MIM #610370</a>)</td> <td><em><a href="https://www.omim.org/entry/604882" target="_blank">NEUROG3</a></em></td> <td>AR</td> <td>Transcription factor-cell fate</td> <td>Watery, diet-induced</td> <td>Normal villus architecture; selective loss of EECs (chromogranin or synaptophysin stains)</td> <td>Later onset of insulin-dependent diabetes (without autoantibodies).</td> </tr> <tr> <td class="indent1"> <p>X-linked lissencephaly</p> (<a href="https://www.omim.org/entry/300215" target="_blank">MIM #300215</a>)</td> <td><em><a href="https://www.omim.org/entry/300382" target="_blank">ARX</a></em></td> <td>X-linked</td> <td>Transcription factor required for neuronal and EEC development</td> <td>Diet-induced</td> <td>Normal villus architecture; possible selective reduction of certain EECs</td> <td>Lissencephaly (smooth cerebral cortex) and severe neurologic abnormalities; seizures; generalized malabsorptive diarrhea.</td> </tr> <tr> <td class="indent1"> <p>Enteric dysendocrinosis</p> (<a href="https://www.omim.org/entry/600955" target="_blank">MIM #600955</a>)</td> <td><em><a href="https://www.omim.org/entry/162150" target="_blank">PCSK1</a></em></td> <td>AR</td> <td>Hormonal endopeptidase</td> <td>Severe diet-induced</td> <td>Normal villus architecture</td> <td>Generalized malabsorption; multiple systemic endocrinopathies (adrenal insufficiency, hypothyroidism, diabetes insipidus); elevated pro-insulin.</td> </tr> <tr> <td class="indent1"> <p>Mitchell-Riley syndrome</p> (<a href="https://www.omim.org/entry/615710" target="_blank">MIM #615710</a>)</td> <td><em><a href="https://www.omim.org/entry/612659" target="_blank">RFX6</a></em></td> <td>AR</td> <td>Transcription factor-cell fate</td> <td>Generalized malabsorption</td> <td>Normal villus architecture and EECs</td> <td>May have intestinal atresia, malrotation, intrinsic and extrinsic biliary duct abnormalities, and neonatal diabetes.</td> </tr> <tr> <td class="indent1"> <p>Congenital malabsorptive diarrhea 11</p> (<a href="https://www.omim.org/entry/618662" target="_blank">MIM #618662</a>)</td> <td><em><a href="https://www.omim.org/entry/618656" target="_blank">PERCC1</a></em></td> <td>AR</td> <td>Required for EEC development</td> <td>Generalized malabsorption</td> <td>Normal villus architecture, reduced EECs</td> <td>Diarrhea.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Immune dysregulation-associated enteropathy<sup>¶</sup></td> </tr> <tr> <td class="indent1"> <p>IPEX</p> (<a href="https://www.omim.org/entry/304790" target="_blank">MIM #304790</a>)</td> <td><em><a href="https://www.omim.org/entry/300292" target="_blank">FOXP3</a></em></td> <td>X-linked</td> <td>Regulatory T cell</td> <td>Watery, mucoid, or bloody</td> <td>Villus atrophy; nonspecific features of autoimmune enteropathy; inflammation</td> <td>Immune dysregulation; polyendocrinopathy (diabetes, thyroiditis); enteropathy X-linked (only males affected). Diarrhea persists with fasting. Food allergies common.</td> </tr> <tr> <td class="indent1"> <p>CD55 deficiency</p> (<a href="https://www.omim.org/entry/226300" target="_blank">MIM #226300</a>)</td> <td><em><a href="https://www.omim.org/entry/125240" target="_blank">CD55</a></em></td> <td>AR</td> <td>Complement cascade inhibitor</td> <td>Watery or bloody; generalized malabsorption</td> <td>Inflammatory</td> <td>Severe protein-losing enteropathy (low Igs and albumin, elevated stool AAT); thrombosis; mucosal ulcers.</td> </tr> <tr> <td class="indent1"> <p>Neonatal inflammatory skin and bowel disease-1 (NISBD1)</p> (<a href="https://www.omim.org/entry/614328" target="_blank">MIM #614328</a>)</td> <td><em><a href="https://www.omim.org/entry/603639" target="_blank">ADAM17</a></em></td> <td>AR</td> <td>TNF-alpha-converting enzyme</td> <td>Watery or bloody; generalized malabsorption</td> <td>Focal villous atrophy; minimal crypt hyperplasia</td> <td>Neonatal onset of severe inflammatory skin rash, diarrhea, and recurrent infections.</td> </tr> <tr> <td class="indent1"> <p>Neonatal inflammatory skin and bowel disease-2 (NISBD2)</p> (<a href="https://www.omim.org/entry/616069" target="_blank">MIM #616069</a>)</td> <td><em><a href="https://www.omim.org/entry/131550" target="_blank">EGFR</a></em></td> <td>AR</td> <td>EGF receptor</td> <td>Watery</td> <td>Normal</td> <td>Similar to NISBD1.</td> </tr> <tr> <td class="indent1"> <p>Lymphoproliferative syndrome, X-linked</p> (<a href="https://www.omim.org/entry/300635" target="_blank">MIM #300635</a>)</td> <td><em><a href="https://www.omim.org/entry/300079" target="_blank">XIAP</a></em> (<em>BIRC4</em>)</td> <td>X-linked</td> <td>Inhibitor of apoptosis</td> <td>Bloody</td> <td>Inflammatory</td> <td>Associated with recurrent infections, hemophagocytic lymphohistiocytosis characteristics, and colitis.</td> </tr> <tr> <td class="indent1"> <p>Common variable immunodeficiency (CVID), type 1</p> (<a href="https://www.omim.org/entry/607594" target="_blank">MIM #607594</a>)</td> <td><em><a href="https://www.omim.org/entry/604558" target="_blank">ICOS</a></em></td> <td>AR</td> <td>T cell receptor</td> <td>Watery</td> <td>Inflammatory; depletion of plasma cells</td> <td>Form of CVID with low Igs and B cells. Severe diarrhea; recurrent infections (sinusitis, bronchitis); lymphadenopathy. Typically presents during childhood but occasionally in infants.</td> </tr> <tr> <td class="indent1"> <p>Autoimmune lymphoproliferative syndrome, type 5 (<em>CTLA4</em> deficiency)</p> (<a href="https://www.omim.org/entry/616100" target="_blank">MIM #616100</a>)</td> <td><em><a href="https://www.omim.org/entry/123890" target="_blank">CTLA4</a></em></td> <td>AD</td> <td>Costimulatory signaling</td> <td>Watery or bloody</td> <td>Inflammatory; lymphocytic infiltration</td> <td>Interstitial lung disease; autoimmune thrombocytopenia; lymphocytic infiltration in various organs including the intestine. Some patients have features of CVID.</td> </tr> <tr> <td class="indent1"> <p>Common variable immunodeficiency (CVID), type 8 (<em>LRBA</em> deficiency)</p> (<a href="https://www.omim.org/entry/614700" target="_blank">MIM #614700</a>)</td> <td><em><a href="https://www.omim.org/entry/606453" target="_blank">LRBA</a></em></td> <td>AR</td> <td>Endosomal trafficking regulator</td> <td>Watery or bloody</td> <td>Inflammatory; loss of plasma cells</td> <td>Form of CVID that may present with diarrheal symptoms during early infancy. Low Igs.</td> </tr> <tr> <td class="indent1"> <p>Common variable immunodeficiency (CVID), type 10 (<em>NFKB2</em> deficiency)</p> (<a href="https://www.omim.org/entry/615577" target="_blank">MIM #615577</a>)</td> <td><em><a href="https://www.omim.org/entry/164012" target="_blank">NFKB2</a></em></td> <td>AD</td> <td>Required for induction of secondary lymphoid tissue and for T helper and Treg function</td> <td>Watery or bloody</td> <td>Inflammatory; recurrent infections</td> <td>Form of CVID that results in diarrheal symptoms and recurrent infections; may have associated central adrenal insufficiency.</td> </tr> <tr> <td class="indent1"> <p>Immunodeficiency, type 12 (<em>MALT1</em> deficiency)</p> (<a href="https://www.omim.org/entry/615468" target="_blank">MIM #615468</a>)</td> <td><em><a href="https://www.omim.org/entry/604860" target="_blank">MALT1</a></em></td> <td>AR</td> <td>Required for T and B cell activation</td> <td>Watery or bloody</td> <td>Inflammatory</td> <td>Form of combined immunodeficiency that may present with diarrheal symptoms during early infancy; dysmorphic facies and poor growth.</td> </tr> <tr> <td class="indent1"> <p>Inflammatory bowel disease (IBD), type 28 (<em>IL10RA</em> deficiency)</p> (<a href="https://www.omim.org/entry/613148" target="_blank">MIM #613148</a>)</td> <td><em><a href="https://www.omim.org/entry/146933" target="_blank">IL10RA</a></em></td> <td>AR</td> <td>IL-10 receptor is required for antiinflammatory role of IL-10</td> <td>Watery or bloody</td> <td>Inflammatory</td> <td>Form of early-onset IBD with immune dysregulation that can result in enteric fistulas and perirectal abscess within several months of life.</td> </tr> <tr> <td class="indent1"> <p>Chronic granulomatous disease, X-linked</p> (<a href="https://www.omim.org/entry/306400" target="_blank">MIM #306400</a>)</td> <td><em><a href="https://www.omim.org/entry/300481" target="_blank">CYBB</a></em></td> <td>X-linked</td> <td>Impaired superoxide</td> <td>Watery or bloody</td> <td>Inflammatory; with granulomas</td> <td>Severe recurrent infections.</td> </tr> <tr> <td class="subtitle3_left_align" colspan="7">Intestinal stem cell factors</td> </tr> <tr> <td class="indent1"> <p>Neonatal-onset chronic diarrhea-9</p> (<a href="https://www.omim.org/entry/618168" target="_blank">MIM #618168</a>)</td> <td><a href="https://www.omim.org/entry/601968" target="_blank"><em>WNT2B</em></a></td> <td>AR</td> <td>Cell-cell signaling factor</td> <td>Watery</td> <td>Crypt hypoplasia; enteroendocrine hyperplasia; atrophic gastritis</td> <td>Occulo-intestinal syndrome (anterior chamber abnormalities such as corneal clouding).</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>CODEs: congenital diarrheas and enteropathies; AR: autosomal recessive; AD: autosomal dominant; ETRD: electrolyte transport-related diarrhea; NHE3: sodium-hydrogen exchanger 3; IBD: inflammatory bowel disease; PAS: periodic acid-Schiff; LDL: low-density lipoprotein; SCID: severe combined immunodeficiency; TNF-alpha: tumor necrosis factor-alpha; EEC: endometrial echo complex; Igs: immunoglobulins; AAT: alpha-1 antitrypsin; EGF: epidermal growth factor; CVID: common variable immunodeficiency; Treg: regulatory T cells; IL: interleukin.</p>
<p>* ETRD is also known as secretory diarrhea. We prefer the term ETRD because this acknowledges that the pathology may include either abnormal secretion or abnormal absorption of electrolytes.</p>
¶ Immune dysregulation-associated enteropathies include a group of disorders sometimes known as very early-onset IBD (VEO-IBD). For a discussion of the clinical presentation and evaluation of VEO-IBD, refer to UpToDate content on clinical presentation of IBD in children and Uhlig HH, et al<sup>[1]</sup>.</div><div class="graphic_reference">References:
<ol>
<li>Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014; 147:990.</li>
<li>Uchida T, Suzuki T, Kikuchi A, et al. Comprehensive Targeted Sequencing Identifies Monogenic Disorders in Patients With Early-onset Refractory Diarrhea. J Pediatr Gastroenterol Nutr 2020; 71:333.</li>
</ol>
<p class="extra_spacing_top">Original table modified for this publication. From: Thiagarajah JR, Kamin DS, Acra S, et al. Advances in evaluation of chronic diarrhea in infants. Gastroenterology 2018. Table used with the permission of Elsevier Inc. All rights reserved.</p></div><div id="graphicVersion">Graphic 117908 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
